Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jonathan M. Goodwin, Anthony D. Schmitt, Christopher M. McGinn, Bryan C. Fuchs, Darshini Kuruppu, Kenneth K. Tanabe & Michael Lanuti. (2012) Angiogenesis Inhibition Using an Oncolytic Herpes Simplex Virus Expressing Endostatin in a Murine Lung Cancer Model. Cancer Investigation 30:3, pages 243-250.
Read now
Read now
Richard G Everson, Mathias Gromeier & John H Sampson. (2007) Viruses in the treatment of malignant glioma. Expert Review of Neurotherapeutics 7:4, pages 321-324.
Read now
Read now
Articles from other publishers (28)
Wataru Matsunaga & Akinobu Gotoh. (2023) Adenovirus as a Vector and Oncolytic Virus. Current Issues in Molecular Biology 45:6, pages 4826-4840.
Crossref
Crossref
Darshini Kuruppu, Deepak Bhere, Christian T. Farrar, Khalid Shah, Anna-Liisa Brownell, Umar Mahmood & Kenneth K. Tanabe. (2023) Oncolytic HSV1 targets different growth phases of breast cancer leptomeningeal metastases. Cancer Gene Therapy 30:6, pages 833-844.
Crossref
Crossref
Omeed Moaven, Christopher W. Mangieri, John A. Stauffer, Panos Z. Anastasiadis & Mitesh J. Borad. (2021) Evolving Role of Oncolytic Virotherapy: Challenges and Prospects in Clinical Practice. JCO Precision Oncology:5, pages 432-441.
Crossref
Crossref
Omeed Moaven, Christopher W. Mangieri, John A. Stauffer, Panos Z. Anastasiadis & Mitesh J. Borad. (2021) Strategies to Develop Potent Oncolytic Viruses and Enhance Their Therapeutic Efficacy. JCO Precision Oncology:5, pages 733-743.
Crossref
Crossref
Federico Armando, Adnan Fayyad, Stefanie Arms, Yvonne Barthel, Dirk Schaudien, Karl Rohn, Matteo Gambini, Mara Sophie Lombardo, Andreas Beineke, Wolfgang Baumgärtner & Christina Puff. (2021) Intratumoral Canine Distemper Virus Infection Inhibits Tumor Growth by Modulation of the Tumor Microenvironment in a Murine Xenograft Model of Canine Histiocytic Sarcoma. International Journal of Molecular Sciences 22:7, pages 3578.
Crossref
Crossref
F. Adi-Kusumo, L. Aryati, S. Risdayati & S. Norhidayah. (2020) Hopf Bifurcation on a Cancer Therapy Model by Oncolytic Virus Involving the Malignancy Effect and Therapeutic Efficacy. International Journal of Mathematics and Mathematical Sciences 2020, pages 1-8.
Crossref
Crossref
Abdelaziz Chetouani. 2020. Disease Prevention and Health Promotion in Developing Countries. Disease Prevention and Health Promotion in Developing Countries
133
147
.
Austin B. Carpenter. (2019) Recombinant Oncolytic Poliovirus for Glioblastoma: A Current Review of PVS(RIPO). Georgetown Medical Review 3:1.
Crossref
Crossref
A. Ashyani, O. RabieiMotlagh & H.M. Mohammadinejad. (2018) A mathematical approach to effects of CTLs on cancer virotherapy in the second injection of virus. Journal of Theoretical Biology 453, pages 78-87.
Crossref
Crossref
Namit Holay, Youra Kim, Patrick Lee & Shashi GujarGujarGujar. (2017) Sharpening the Edge for Precision Cancer Immunotherapy: Targeting Tumor Antigens through Oncolytic Vaccines. Frontiers in Immunology 8.
Crossref
Crossref
D Kuruppu & K K Tanabe. (2015) HSV-1 as a novel therapy for breast cancer meningeal metastases. Cancer Gene Therapy 22:10, pages 506-508.
Crossref
Crossref
Pei-Hsin Cheng, Xiao-Mei Rao, Xiaoxian Duan, Xiao-Feng Li, Michael E. Egger, Kelly M. McMasters & H. Sam Zhou. (2014) Virotherapy targeting cyclin E overexpression in tumors with adenovirus-enhanced cancer-selective promoter. Journal of Molecular Medicine 93:2, pages 211-223.
Crossref
Crossref
Kenichi W. Okamoto, Priyanga Amarasekare & Ian T.D. Petty. (2014) Modeling oncolytic virotherapy: Is complete tumor-tropism too much of a good thing?. Journal of Theoretical Biology 358, pages 166-178.
Crossref
Crossref
Darshini Kuruppu, Anna-Liisa Brownell, Khalid Shah, Umar Mahmood & Kenneth K. Tanabe. (2014) Molecular Imaging with Bioluminescence and PET Reveals Viral Oncolysis Kinetics and Tumor Viability. Cancer Research 74:15, pages 4111-4121.
Crossref
Crossref
B J Passer, T Cheema, S Wu, C-l Wu, S D Rabkin & R L Martuza. (2012) Combination of vinblastine and oncolytic herpes simplex virus vector expressing IL-12 therapy increases antitumor and antiangiogenic effects in prostate cancer models. Cancer Gene Therapy 20:1, pages 17-24.
Crossref
Crossref
P. M. Chumakov, V. V. Morozova, I. V. Babkin, I. K. Baikov, S. V. Netesov & N. V. Tikunova. (2012) Oncolytic enteroviruses. Molecular Biology 46:5, pages 639-650.
Crossref
Crossref
Aisha Q. Butt & Sinéad M. Miggin. (2012) Cancer and viruses: A double‐edged sword. PROTEOMICS 12:13, pages 2127-2138.
Crossref
Crossref
Stephanie Weibel, Viktoria Raab, Yong A Yu, Andrea Worschech, Ena Wang, Francesco M Marincola & Aladar A Szalay. (2011) Viral-mediated oncolysis is the most critical factor in the late-phase of the tumor regression process upon vaccinia virus infection. BMC Cancer 11:1.
Crossref
Crossref
Elizabeth M. Hadac, Mark J. Federspiel, Evgeny Chernyy, Alexander Tuzikov, Elena Korchagina, Nicolai V. Bovin, Stephen Russell & Stephen M. Henry. (2011) Fluorescein and radiolabeled Function-Spacer-Lipid constructs allow for simple in vitro and in vivo bioimaging of enveloped virions. Journal of Virological Methods 176:1-2, pages 78-84.
Crossref
Crossref
Mina Hikichi, Minoru Kidokoro, Takeshi Haraguchi, Hideo Iba, Hisatoshi Shida, Hideaki Tahara & Takafumi Nakamura. (2011) MicroRNA Regulation of Glycoprotein B5R in Oncolytic Vaccinia Virus Reduces Viral Pathogenicity Without Impairing Its Antitumor Efficacy. Molecular Therapy 19:6, pages 1107-1115.
Crossref
Crossref
Manju Agarwal & Archana S. Bhadauria. (2011) Mathematical Modeling and Analysis of Tumor Therapy with Oncolytic Virus. Applied Mathematics 02:01, pages 131-140.
Crossref
Crossref
Daisuke Watanabe, Fumi Goshima, Isamu Mori, Yasuhiko Tamada, Yoshinari Matsumoto & Yukihiro Nishiyama. (2008) Oncolytic virotherapy for malignant melanoma with herpes simplex virus type 1 mutant HF10. Journal of Dermatological Science 50:3, pages 185-196.
Crossref
Crossref
Peter Forsyth, Gloria Rold?n, David George, Carla Wallace, Cheryl Ann Palmer, Don Morris, Gregory Cairncross, Maureen Vallee Matthews, James Markert, Yancey Gillespie, Matt Coffey, Brad Thompson & Mark Hamilton. (2008) A Phase I Trial of Intratumoral Administration of Reovirus in Patients With Histologically Confirmed Recurrent Malignant Gliomas. Molecular Therapy 16:3, pages 627-632.
Crossref
Crossref
Zang-Hee Cho, Young-Don Son, Hang-Keun Kim, Kyoung-Nam Kim, Se-Hong Oh, Jae-Yong Han, In-Ki Hong & Young-Bo Kim. (2008) A fusion PET–MRI system with a high-resolution research tomograph-PET and ultra-high field 7.0 T-MRI for the molecular-genetic imaging of the brain. PROTEOMICS 8:6, pages 1302-1323.
Crossref
Crossref
Marianne M Stanford, Mae Shaban, John W Barrett, Steven J Werden, Philippe-Alexandre Gilbert, Joe Bondy-Denomy, Lisa MacKenzie, Kevin C Graham, Ann F Chambers & Grant McFadden. (2008) Myxoma Virus Oncolysis of Primary and Metastatic B16F10 Mouse Tumors In Vivo. Molecular Therapy 16:1, pages 52-59.
Crossref
Crossref
Kerrington D SmithMichael Y ShaoMitchell C PosnerRalph R Weichselbaum. (2007) Tumor genotype determines susceptibility to oncolytic herpes simplex virus mutants: strategies for clinical application. Future Oncology 3:5, pages 545-556.
Crossref
Crossref
Susan Varghese, Samuel D. Rabkin, G. Petur Nielsen, Usha MacGarvey, Renbin Liu & Robert L. Martuza. (2007) Systemic Therapy of Spontaneous Prostate Cancer in Transgenic Mice with Oncolytic Herpes Simplex Viruses. Cancer Research 67:19, pages 9371-9379.
Crossref
Crossref
Kenneth K. Tanabe. (2006) Emerging therapies for metastatic carcinoma to the liver. Community Oncology 3:9, pages 567-573.
Crossref
Crossref